Anna Shcherbina

7.0k total citations
107 papers, 1.0k citations indexed

About

Anna Shcherbina is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Anna Shcherbina has authored 107 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Immunology, 38 papers in Hematology and 27 papers in Genetics. Recurrent topics in Anna Shcherbina's work include Immunodeficiency and Autoimmune Disorders (51 papers), Blood disorders and treatments (21 papers) and Platelet Disorders and Treatments (21 papers). Anna Shcherbina is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (51 papers), Blood disorders and treatments (21 papers) and Platelet Disorders and Treatments (21 papers). Anna Shcherbina collaborates with scholars based in Russia, United States and Germany. Anna Shcherbina's co-authors include Eileen Remold‐O’Donnell, Fred S. Rosen, Dianne M. Kenney, Anthony Bretscher, А.П. Продеус, Jessica Cooley, Alexandra Laberko, Michael Maschan, Dmitry Balashov and G. А. Novichkova and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Anna Shcherbina

85 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Shcherbina Russia 18 369 357 301 258 253 107 1.0k
Mark Hoogenboezem Netherlands 20 386 1.0× 112 0.3× 244 0.8× 259 1.0× 441 1.7× 37 1.1k
Erin Janssen United States 17 952 2.6× 340 1.0× 210 0.7× 60 0.2× 339 1.3× 34 1.4k
Phil Ancliff United Kingdom 15 349 0.9× 230 0.6× 101 0.3× 120 0.5× 225 0.9× 25 871
Timothy Burke United States 10 207 0.6× 430 1.2× 624 2.1× 107 0.4× 373 1.5× 16 1.1k
Brigitte Kasper Germany 15 574 1.6× 412 1.2× 92 0.3× 72 0.3× 173 0.7× 22 1.0k
K A Siminovitch Canada 18 548 1.5× 89 0.2× 129 0.4× 102 0.4× 353 1.4× 22 1.2k
Adam Asch United States 8 371 1.0× 118 0.3× 289 1.0× 48 0.2× 171 0.7× 27 689
K Sugita Japan 21 737 2.0× 270 0.8× 198 0.7× 32 0.1× 329 1.3× 41 1.4k
Caroline Johnson‐Léger Switzerland 15 656 1.8× 81 0.2× 285 0.9× 116 0.4× 355 1.4× 19 1.2k
James Bell United Kingdom 14 373 1.0× 109 0.3× 110 0.4× 68 0.3× 297 1.2× 22 1.1k

Countries citing papers authored by Anna Shcherbina

Since Specialization
Citations

This map shows the geographic impact of Anna Shcherbina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Shcherbina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Shcherbina more than expected).

Fields of papers citing papers by Anna Shcherbina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Shcherbina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Shcherbina. The network helps show where Anna Shcherbina may publish in the future.

Co-authorship network of co-authors of Anna Shcherbina

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Shcherbina. A scholar is included among the top collaborators of Anna Shcherbina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Shcherbina. Anna Shcherbina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mukhinа, Anna, Dmitry Pershin, Dmitry Meleshko, et al.. (2025). 13q Deletion Syndrome Presenting with Lymphopenia Detected Through Newborn Screening for Primary Immunodeficiencies. International Journal of Molecular Sciences. 26(19). 9302–9302.
2.
Martyanov, A. A., et al.. (2024). Dissecting thrombus-directed chemotaxis and random movement in neutrophil near-thrombus motion in flow chambers. BMC Biology. 22(1). 115–115. 2 indexed citations
4.
Deripapa, Elena, et al.. (2023). Experience with the use of Hizentra, an immunoglobulin preparation for subcutaneous administration, in patients with primary immunodeficiency diseases. Pediatric Hematology/Oncology and Immunopathology. 22(2). 92–97.
5.
Mukhinа, Anna, et al.. (2022). An autoinflammatory disease – PFAPA syndrome: a single-center experience. Pediatric Hematology/Oncology and Immunopathology. 21(3). 56–64.
6.
Morozova, Daria, A. A. Martyanov, Sokolov Av, et al.. (2022). Ex vivo observation of granulocyte activity during thrombus formation. BMC Biology. 20(1). 32–32. 8 indexed citations
7.
Vishneva, Еlena A., et al.. (2021). Hereditary angioedema. Clinical guidelines. (D84.1). Russian Journal of Allergy. 18(2). 77–114. 2 indexed citations
8.
Pavlova, Anna, Irina Mersiyanova, Anna Mukhinа, et al.. (2021). Evans syndrome in children: the results of a retrospective study of 54 patients. Pediatric Hematology/Oncology and Immunopathology. 20(2). 74–83.
9.
Pavlova, Anna, et al.. (2021). THE MANY FACES OF AUTOINFLAMMATION: ADENOSINE DEAMINASE 2 (DADA2) DEFICIENCY IN A 12 YEAR OLD. PEDIATRIA Journal named after G N SPERANSKY. 100(2). 246–253. 1 indexed citations
10.
Balashov, Dmitry, Alexandra Laberko, K. A. Voronin, et al.. (2020). EFFICACY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM AN ALTERNATIVE DONOR ON THE PLATFORM OF TRANSPLANT CELL MODELING TECHNOLOGY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES. PEDIATRIA Journal named after G N SPERANSKY. 99(2). 43–51. 2 indexed citations
11.
Pershin, Dmitry, et al.. (2020). Development of flow cytometry assay for Wiskott–Aldrich syndrome diagnosis by WASP protein evaluation. Pediatric Hematology/Oncology and Immunopathology. 19(2). 141–151. 1 indexed citations
12.
Pershin, Dmitry, et al.. (2020). Verification of X-linked lymphoproliferative syndrome type 1 and 2 using a flow cytometry method. Pediatric Hematology/Oncology and Immunopathology. 19(4). 108–118.
13.
Pavlova, Anna, et al.. (2019). Clericusio syndrome (poikiloderm with neutropenia). Pediatric Hematology/Oncology and Immunopathology. 18(3). 96–103. 1 indexed citations
14.
Shcherbina, Anna, et al.. (2019). AUTOINFLAMMATORY DISEASES. PEDIATRIA Journal named after G N SPERANSKY. 98(3). 227–234. 1 indexed citations
15.
Shcherbina, Anna, et al.. (2019). MODERN VIEWS ON IMMUNOPATHOLOGICAL ASPECTS AND METHODS OF TREATMENT OF GLYCOGEN STORAGE DISEASE. PEDIATRIA Journal named after G N SPERANSKY. 98(3). 253–257.
16.
Balashov, Dmitry, Alexandra Laberko, Anna Shcherbina, et al.. (2018). A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ+ and CD19+ Cell-Depleted Stem Cell Transplantation in Patients with Wiskott-Aldrich Syndrome. Biology of Blood and Marrow Transplantation. 24(7). 1432–1440. 20 indexed citations
18.
Shcherbina, Anna. (2016). Masks of primary immunodeficiency disorders: diagnostic and therapeutic problems. Russian Journal of Pediatric Hematology and Oncology. 3(1). 52–58. 8 indexed citations
19.
Shcherbina, Anna. (2015). Autoinflammatory diseases: An immunologist’s view. SHILAP Revista de lepidopterología. 48–48. 6 indexed citations
20.
Shcherbina, Anna, et al.. (2014). Radiological features of malignant osteopetrosis at early and late stages of disease. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026